NCT00227357View on ClinicalTrials.gov

The CORE Buprenorphine Project - An HIV Primary Care Program Demonstration

CompletedOBSERVATIONAL
Enrollment

101

Participants

Timeline

Start Date

July 31, 2005

Primary Completion Date

December 31, 2008

Study Completion Date

December 31, 2008

Conditions
HIV InfectionsAIDSOpiate DependencePost-Traumatic Stress Disorders
Interventions
DRUG

On-site - buprenorphine/naloxone (Suboxone)

Tablet, sub-lingual, 8/2 mg, 1-3 daily

DRUG

Off-site - methadone or no agonist

Trial Locations (1)

60612

The CORE Center, Chicago

All Listed Sponsors
collaborator

Health Resources and Services Administration (HRSA)

FED

collaborator

The New York Academy of Medicine

OTHER

lead

Ruth M. Rothstein CORE Center

OTHER

NCT00227357 - The CORE Buprenorphine Project - An HIV Primary Care Program Demonstration | Biotech Hunter | Biotech Hunter